Table of Contents Author Guidelines Submit a Manuscript
International Journal of Chronic Diseases
Volume 2014 (2014), Article ID 789340, 6 pages
http://dx.doi.org/10.1155/2014/789340
Clinical Study

Evaluation of Rhubarb Supplementation in Stages 3 and 4 of Chronic Kidney Disease: A Randomized Clinical Trial

1Departments of Pharmacology, JNMCH, AMU, Aligarh 202002, India
2Department of Medicine, JNMCH, AMU, Aligarh 202002, India

Received 19 June 2014; Revised 29 August 2014; Accepted 4 September 2014; Published 11 September 2014

Academic Editor: Jens Klotsche

Copyright © 2014 Irfan A. Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, supplement 1, no. 2, pp. S1–S266, 2002. View at Google Scholar
  2. A. K. Singh, Y. M. K. Farag, B. V. Mittal et al., “Epidemiology and risk factors of chronic kidney disease in India—results from the SEEK (Screening and Early Evaluation of Kidney Disease) study,” BMC Nephrology, vol. 14, no. 1, article 114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Sakhuja and K. Sud, “End-stage renal disease in India and Pakistan: Burden of disease and management issues,” Kidney International, Supplement, vol. 63, supplement 83, pp. S115–S118, 2003. View at Google Scholar · View at Scopus
  4. D. Fouque, M. Laville, and J. P. Boissel, “Low protein diets for chronic kidney disease in non diabetic adults,” Cochrane Database of Systematic Reviews, vol. 2, 2006. View at Google Scholar · View at Scopus
  5. J. M. Bargman and K. Skorecki, “Chapter 280. Chronic kidney disease,” in Harrison's Principles of Internal Medicine, 18th edition, 2012. View at Google Scholar
  6. L.-L. Gao, X.-D. Xu, H.-J. Nan, J.-S. Yang, and S.-L. Chen, “Chemical constituents in Rheum tanguticum,” Chinese Traditional and Herbal Drugs, vol. 42, no. 3, pp. 443–446, 2011. View at Google Scholar · View at Scopus
  7. L. Li, “End-stage renal disease in China,” Kidney International, vol. 49, no. 1, pp. 287–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Li, S.-C. Wang, X. Wang et al., “Novel exploration of cathartic pharmacology induced by rhubarb,” China Journal of Chinese Materia Medica, vol. 33, no. 4, pp. 481–484, 2008. View at Google Scholar · View at Scopus
  9. W. S. Zhang, F. Li, and J. Q. Bao, “Regulatory effect of anthraquinone derivatives from rhubarb on aquaporin 4 expression in colon of rats and in LoVo cell line,” Chinese Journal of Integrated Traditional and Western Medicinejiu, vol. 28, no. 9, pp. 818–823, 2008. View at Google Scholar · View at Scopus
  10. Y. L. Zhao, Z. H. Zhang, Z. R. Wang, and T. Xia, “Relationship between drastic effect of rhubarb and 5-HT and its receptor in Duodenum tissues,” Journal of Yunnan College of Traditional Chinese Medicine, vol. 25, no. 1, pp. 1–3, 2002. View at Google Scholar
  11. Q. Gao, W.-S. Qin, Z.-H. Jia et al., “Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy,” Planta Medica, vol. 76, no. 1, pp. 27–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. X. M. Zhou and Q. H. Chen, “Studies on Chinese rhubarb: XXII, inhibitory effect of anthraquinone derivatives on Na+-K+-ATPase of rabbit renal medulla and their diuretic action,” Acta Pharmaceutica Sinica, vol. 23, pp. 17–20, 1988. View at Google Scholar
  13. C. A. Naranjo, U. Busto, and E. M. Sellers, “A method for estimating the probability of adverse drug reactions,” Clinical Pharmacology and Therapeutics, vol. 30, no. 2, pp. 239–245, 1981. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Hartwig, J. Siegel, and P. J. Schneider, “Preventability and severity assessment in reporting adverse drug reactions,” American Journal of Hospital Pharmacy, vol. 49, no. 9, pp. 2229–2232, 1992. View at Google Scholar · View at Scopus
  15. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes :estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Gupta, “Trends in hypertension epidemiology in India,” Journal of Human Hypertension, vol. 18, no. 2, pp. 73–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Kher, “End-stage renal disease in developing countries,” Kidney International, vol. 62, no. 1, pp. 350–362, 2002. View at Google Scholar
  18. R. Ye, Y. Li, and D. Sun, “Clinical study of the therapeutic effects of rhubarb as a main drug in the treatment of chronic renal failure,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 1, no. 2, pp. 104–107, 1995. View at Google Scholar
  19. H. Sanada, “Study on the clinical effect of rhubarb on nitrogen-metabolism abnormality due to chronic renal failure and its mechanism,” Nippon Jinzo Gakkai Shi, vol. 38, no. 8, pp. 379–387, 1996. View at Google Scholar · View at Scopus
  20. Q. Gao, W. S. Qin, Z. H. Jia et al., “Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy,” Planta Medica, vol. 76, no. 1, pp. 27–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. H. Liu, L. S. Li, W. X. Hu, and H. Zhou, “Effect of Emodin on c-myc proto-oncogene expression in mesangial cells,” Nephrology Dialysis Transplantation, vol. 1, pp. 27–30, 1992. View at Google Scholar
  22. W. X. Hu, L. S. Li, and J. Yao, “Rheum officinale inhibited the production of interleukin 1 and tumor necrosis factor by macrophages,” Bulletin of the Jinling Hospital, vol. 4, pp. 404–407, 1991. View at Google Scholar
  23. Z. H. Liu, L. S. Li, W. X. Hu, and H. Zhou, “Effect of IL-6 on c-myc proto-oncogene expression in human mesangial cells and the down regulation by Emodin,” Nephrology Dialysis Transplantation, vol. 2, pp. 58–61, 1993. View at Google Scholar